Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes.
Stuver R, Dusza S, Epstein-Peterson ZD, Ghione P, Horwitz SM, Johnson W, Moskowitz AJ, Myskowski P, Pulitzer M, Geller S. Stuver R, et al. Among authors: myskowski p. J Eur Acad Dermatol Venereol. 2024 May 31:10.1111/jdv.20141. doi: 10.1111/jdv.20141. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38818876 No abstract available.
Dermoscopic spectrum of mycosis fungoides: a retrospective observational study by the International Dermoscopy Society.
Errichetti E, Apalla Z, Geller S, Sławińska M, Kyrgidis A, Kaminska-Winciorek G, Jurakic Toncic R, Bobos M, Rados J, Ledic Drvar D, Ceovic R, Akay BN, Piccolo V, Myskowski P, Vitiello P, Russo T, Argenziano G, Sokołowska-Wojdyło M, Sobjanek M, Stojkovic-Filipovic J, Longo C, Pellacani G, Stinco G, Lallas A. Errichetti E, et al. Among authors: myskowski p. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):1045-1053. doi: 10.1111/jdv.18078. Epub 2022 Mar 28. J Eur Acad Dermatol Venereol. 2022. PMID: 35285088 Free PMC article.
Dermatoscopy of nodular/plaque-type primary cutaneous T- and B-cell lymphomas: A retrospective comparative study with pseudolymphomas and tumoral/inflammatory mimickers by the International Dermoscopy Society.
Errichetti E, Geller S, Zalaudek I, Longo C, Kyrgidis A, Akay BN, Piccolo V, Myskowski P, Vitiello P, Russo T, Argenziano G, Sławińska M, Sokołowska-Wojdyło M, Sobjanek M, Toncic RJ, Rados J, Drvar DL, Ceovic R, Kaminska-Winciorek G, Zaballos P, Reggiani C, Kremic Z, Lanssens S, Güleç AT, Lobato-Berezo A, Damiani G, Maione V, Calzavara-Pinton P, Sotiriou E, Stinco G, Apalla Z, Lallas A. Errichetti E, et al. Among authors: myskowski p. J Am Acad Dermatol. 2022 Apr;86(4):774-781. doi: 10.1016/j.jaad.2021.10.020. Epub 2021 Oct 23. J Am Acad Dermatol. 2022. PMID: 34695527 Free article.
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas.
Moskowitz AJ, Ghione P, Jacobsen E, Ruan J, Schatz JH, Noor S, Myskowski P, Vardhana S, Ganesan N, Hancock H, Davey T, Perez L, Ryu S, Santarosa A, Dowd J, Obadi O, Pomerantz L, Yi N, Sohail S, Galasso N, Neuman R, Liotta B, Blouin W, Baik J, Geyer MB, Noy A, Straus D, Kumar P, Dogan A, Hollmann T, Drill E, Rademaker J, Schoder H, Inghirami G, Weinstock DM, Horwitz SM. Moskowitz AJ, et al. Among authors: myskowski p. Blood. 2021 Dec 30;138(26):2828-2837. doi: 10.1182/blood.2021013379. Blood. 2021. PMID: 34653242 Free PMC article. Clinical Trial.
Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts.
Mehta-Shah N, Lunning MA, Moskowitz AJ, Boruchov AM, Ruan J, Lynch P, Hamlin PA, Leonard J, Matasar MJ, Myskowski PL, Marzouk E, Nair S, Sholklapper T, Minnal V, Palomba ML, Vredenburgh J, Kumar A, Noy A, Straus DJ, Zelenetz AD, Schoder H, Rademaker J, Schaffer W, Galasso N, Ganesan N, Horwitz SM. Mehta-Shah N, et al. Among authors: myskowski pl. Am J Hematol. 2021 Oct 1;96(10):1211-1222. doi: 10.1002/ajh.26288. Epub 2021 Jul 29. Am J Hematol. 2021. PMID: 34251048 Free PMC article. Clinical Trial.
153 results